Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Dentalklinikken BALLERUP ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.5% 4.6% 2.2% 1.5% 1.5% 1.3% 7.1% 7.1%   Credit score (0-100)   64 46 64 75 76 80 34 34   Credit rating   BBB BBB BBB A A A BBB BBB   Credit limit (kDKK)   0.0 0.0 0.2 26.7 38.6 143.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,820 8,331 9,644 10,410 8,585 11,613 0.0 0.0   EBITDA   1,306 3,192 2,786 3,214 834 2,513 0.0 0.0   EBIT   558 2,434 2,027 2,735 348 1,986 0.0 0.0   Pre-tax profit (PTP)   534.5 2,427.5 2,041.0 2,729.4 336.2 1,893.1 0.0 0.0   Net earnings   416.9 1,893.4 1,592.0 2,127.5 262.1 1,476.2 0.0 0.0   Pre-tax profit without non-rec. items   535 2,427 2,041 2,729 336 1,893 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   585 344 44.3 25.2 208 213 0.0 0.0   Shareholders equity total   237 2,130 3,722 5,850 6,112 7,588 2,038 2,038   Interest-bearing liabilities   3,272 411 0.0 0.0 1,504 2,391 0.0 0.0   Balance sheet total (assets)   4,504 4,836 6,567 8,219 9,933 12,086 2,038 2,038   Net Debt   3,208 159 -224 -143 1,386 2,324 -1,118 -1,118     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,820 8,331 9,644 10,410 8,585 11,613 0.0 0.0   Gross profit growth   8.9% 22.2% 15.8% 7.9% -17.5% 35.3% -100.0% 0.0%   Employees   12 11 13 12 14 15 0 0   Employee growth %   -14.3% -8.3% 18.2% -7.7% 16.7% 7.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,504 4,836 6,567 8,219 9,933 12,086 2,038 2,038   Balance sheet change%   -33.0% 7.4% 35.8% 25.1% 20.9% 21.7% -83.1% 0.0%   Added value   1,306.1 3,192.1 2,786.4 3,213.7 827.2 2,513.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,496 -1,459 -1,519 -958 -763 -982 -213 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.2% 29.2% 21.0% 26.3% 4.1% 17.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.8% 52.1% 35.8% 37.0% 3.9% 18.1% 0.0% 0.0%   ROI %   12.0% 77.4% 63.1% 56.0% 5.1% 22.2% 0.0% 0.0%   ROE %   12.0% 160.0% 54.4% 44.5% 4.4% 21.6% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   5.5% 45.4% 57.9% 72.7% 62.9% 64.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   245.6% 5.0% -8.0% -4.5% 166.3% 92.5% 0.0% 0.0%   Gearing %   1,380.8% 19.3% 0.0% 0.0% 24.6% 31.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.5% 0.4% 1.2% 0.0% 1.9% 4.9% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.2 0.9 2.0 4.2 4.4 4.5 0.0 0.0   Current Ratio   0.2 0.8 1.9 3.8 4.0 4.1 0.0 0.0   Cash and cash equivalent   63.1 251.6 223.6 143.3 117.4 67.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,437.9 -324.5 1,951.0 4,671.1 6,242.9 8,307.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   109 290 214 268 59 168 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   109 290 214 268 60 168 0 0   EBIT / employee   47 221 156 228 25 132 0 0   Net earnings / employee   35 172 122 177 19 98 0 0